Skip to content

To study theeEffect of an Ayurvedic Drug Trimurthy Ras for treatment of Medoroga (Dyslipidaemia - Blood fat levels)

Pharmaceutico - Clinical validation of Trimurthy Ras in the management of Medoroga (Dyslipidaemia)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018228
Enrollment
100
Registered
2019-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

Intervention1: Trimurthy Ras: 50 patients will be administered with Trimurthy Ras per oral 500 mg twice daily for 90 days Control Intervention1: Triglize: A group of 50 patients are administered with

Sponsors

Dr Ratna Priya Darsini Y
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients within the age group of 18-60 years will be taken for the study. Patients of either sex with Hyperlipidaemia. Patients with abnormal (borderline high to high) lipid level in blood serum, as per the ATP â??III classification

Exclusion criteria

Exclusion criteria: Age below 18 years and 60 years Known/diagnosed cases of severe renal disease, hepatic disease, coronary heart disease or myocardial infarction and other systemic diseases. Uncontrolled hypertension, diabetes mellitus and malignancy patients Undergoing treatment for any other serious illness Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms and significant improvement of objective parameters tests to 50% baselineTimepoint: Relief in signs and symptoms and significant improvement of objective parameters assessed at 0 30 60 and 90 days

Secondary

MeasureTime frame
Change in Plasma Total Trigicerides, Total Cholesterol, HDL and LDL valuesTimepoint: Treatment period of 90 days Assessment for every 30 days withactive followup of 3 months

Countries

India

Contacts

Public ContactDr Ratna Priya Darsini Y

Regional Ayurveda Research Institute for Skin Diseases, (a unit of CCRAS)

drbabugajji@yahoo.com8096455323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026